Redefining Precision Fluid Management in Cardiorenal Care

Fluid overload remains one of the most complex and costly challenges in cardiorenal care, particularly for patients who no longer respond to conventional d...

May 04, 2026 | Monday | Interview
Cleaning Beyond Compliance: How Biopharma Manufacturers Can Unlock Capacity Through Smarter Contamination Control

  As biologics manufacturing operations become increasingly complex, biopharma companies are under growing pressure to improve efficiency, strengthen...

May 04, 2026 | Monday | Interaction
Circular Genomics and Vitazi.ai Partner to Advance Multimodal Early Detection of Alzheimer’s Disease

Analytical Framework Combines AI-Powered Retinal Imaging with Proprietary Circular RNA Biomarkers to Unlock Scalable, Non-Invasive Pathway for Early-Stag...

May 01, 2026 | Friday | News
Taiho Oncology, Inc. Advances First ADC Candidate ARC-02 into Phase 1 Following U.S. Food and Drug Administration IND Clearance

Taiho Oncology, Inc., Taiho Pharmaceutical Co., Ltd., and Araris Biotech AG (“Araris”) today announced that the U.S. Food and Drug Administra...

April 30, 2026 | Thursday | News
TrialClinIQ Secures Pre-Seed Funding and Accelerator Backing to Advance Equitable Clinical Trial Access

TrialClinIQ, an AI-powered clinical trial recruitment platform based in Houston, Texas advancing health equity, announced a $150K pre-seed investment fro...

April 30, 2026 | Thursday | News
Mesoblast Limited Advances Phase 3 Program for Rexlemestrocel-L with Full Enrollment in Chronic Low Back Pain Trial

Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, announced that its pivotal Phase 3 cl...

April 30, 2026 | Thursday | News
Thermo Fisher Scientific Opens Flagship Bioprocess Design Center in Massachusetts to Accelerate Biologics Development

  Expansion of Plainville, Mass., facility offers bioprocessing expertise, advanced technologies and customized support Thermo Fisher Scientific Inc...

April 29, 2026 | Wednesday | News
Thermo Fisher Scientific to Divest Microbiology Unit to Astorg in $1.075 Billion Deal

Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that it has signed a definitive agreement to sell its microbiol...

April 29, 2026 | Wednesday | News
Sun Pharmaceutical Industries Limited to Acquire Organon & Co. in $11.75 Billion Deal to Expand Global Women’s Health and Biosimilars Footprint

Sun Pharmaceutical Industries Limitedand Organon & Co. announced that they have entered into a definitive agreement under which Sun Pharma will acqui...

April 29, 2026 | Wednesday | News
PCI Pharma Services Commits Over $1 Billion to Expand Sterile Fill-Finish and Drug-Device Capabilities Across US and Europe

PCI Pharma Services (“PCI”) – a world-leading integrated global contract development and manufacturing organization (CDMO) focused on i...

April 29, 2026 | Wednesday | News
CREATE Medicines Doses First Patient in Phase 1/2 Trial of MT-304, Advancing In Vivo Multi-Immune CAR Therapy

Validates platform's ability to rapidly iterate across immune cell types Leverages novel NK and myeloid co-programming architecture to deliver coordin...

April 28, 2026 | Tuesday | News
Repertoire Immune Medicines Doses First Patient in Phase 1/2 Trial of Novel TCR Bispecific RPTR-1-201 for Solid Tumors

Clinical trial will evaluate safety, tolerability and antitumor activity of Repertoire's novel off-the-shelf T cell receptor (TCR) bispecific therapy as ...

April 27, 2026 | Monday | News
Servier Completes $2.5B Acquisition of Day One Biopharmaceuticals, Bolstering Rare Cancer Pipeline with OJEMDA

Acquisition expands Servier's position in oncology with tovorafenib marketed as OJEMDATM in the U.S. in pediatric low-grade gl...

April 27, 2026 | Monday | News
AbbVie Confident in Rapid Path Forward After U.S. Food and Drug Administration Flags Manufacturing Issues in TrenibotE Review

U.S. Food and Drug Administration (FDA) issues Complete Response Letter (CRL) for trenibotulinumtoxinE (TrenibotE) related to manufacturing processes; ...

April 27, 2026 | Monday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2026 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close